Short review to Johnson and Johnson biotechnology company in 2022

Biotech Stocks Biotechnology biotechnology companies

Johnson & Johnson biotechnology company is a leader of biotechnology markets and research in bio science that is active in NYSE stocks market with symbol of JNJ under management of CEO Joaquin Duato. JNJ market cap in 2021 was about 442.93 Billion Dollar .

The top individual shareholder of Johnson and Johnson is CEO Alex Gorsky with 3.2 million shares. Joaquin Duato—J&J’s executive vice president—is the second-largest individual shareholder with one million shares. Paulus Stoffels, Ph. D., is the third-largest individual shareholder with almost 872,000 shares.

JOHNSON & JOHNSON calls itself a family of companies. … Family members continued to rule the executive suite until 1963, when Robert Wood Johnson Jr., the son of the founder, retired as chief executive at age 70.

It includes prescription and over-the-counter drugs, orthopedic implants, surgical products and household products. The most popular consumer brands include Band-Aids, Tylenol and Johnson’s Baby Powder. Still, the bulk of J&J’s revenue comes from prescription drugs and medical devices.

Later in the year, in early October 2021 , the CDC approved the Johnson & Johnson booster after the company shared data—including 94% efficacy against symptomatic disease after a booster—that put its vaccine on par with the mRNA COVID-19 vaccines from Pfizer-BioNTech and Moderna.

Johnson & Johnson competitors include Bristol Myers Squibb, Merck, Unilever, Pfizer and Procter & Gamble. Johnson & Johnson ranks 1st in Employee Net Promoter Score on Comparably vs its competitors.

The multi-billion market cap company has three key segments—pharmaceuticals, medical devices, and consumer products. The pharmaceuticals business makes up roughly over half of J&J’s pretax income, medical devices almost 30%, and the consumer products division making up the rest.

Johnson & Johnson is the largest and most broadly based healthcare company in the world. We’re producing life-changing breakthroughs every day, and have been for the last 130 years. The combination of new technologies and your expertise enables amazing things to happen. Teams from J&J’s consumer business are creating digital tools to help people track the health of their skin. Those working in medical devices are 3-D printing artificial joints personalized for each patient, while researchers in pharmaceuticals use AI to discover lifesaving drugs. Imagine what the rest of our team of 134,000 people at 260 companies in more than 60 countries across the world is accomplishing. We redefine what it means to be a big company in today’s world.

Johnson & Johnson (J&J) is an American multinational corporation founded in 1886 that develops medical devices, pharmaceuticals, and consumer packaged goods. Its common stock is a component of the Dow Jones Industrial Average and the company is ranked No. 36 on the 2021 Fortune 500 list of the largest United States corporations by total revenue. Johnson & Johnson is one of the world’s most valuable companies, and is one of only two U.S.-based companies that has a prime credit rating of AAA, higher than that of the United States government.